T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Grab
GRAB
$15.1B
| $39.7M | 0.01% |
15,708,534
+522,820
| +3% | +$1.5M |
|
952
Petco
WOOF
$817M
| $39.6M | 0.01% |
2,688,630
-1,396,379
| -34% | -$25.4M |
|
953
Clorox
CLX
$12.9B
| $39.6M | 0.01% |
280,590
+55,412
| +25% | +$7.92M |
|
954
Teradyne
TER
$64.2B
| $39.5M | 0.01% |
441,064
-48,733
| -10% | -$5.07M |
|
|
CVET
955
DELISTED
Covetrus, Inc. Common Stock
CVET
| $39.4M | 0.01% |
1,898,101
+66,479
| +4% | +$1.18M |
|
956
Hawkins
HWKN
$2.67B
| $39.4M | 0.01% |
1,092,462
-46,679
| -4% | -$1.76M |
|
957
Eversource Energy
ES
$27.2B
| $39.3M | 0.01% |
465,713
-56,364
| -11% | -$5.01M |
|
958
Repay Holdings
RPAY
$317M
| $39.2M | 0.01% |
3,051,504
-216,755
| -7% | -$2.82M |
|
|
PRFT
959
DELISTED
Perficient Inc
PRFT
| $39M | ﹤0.01% |
425,220
+10,318
| +2% | +$1.03M |
|
|
KAHC.U
960
DELISTED
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
| $38.5M | ﹤0.01% |
3,894,573
+33,500
| +0.9% | +$332K |
|
|
CHCT
961
Community Healthcare Trust
CHCT
$433M
| $38.3M | ﹤0.01% |
1,057,058
+10,517
| +1% | +$394K |
|
962
i3 Verticals
IIIV
$325M
| $38.1M | ﹤0.01% |
1,523,938
-21,525
| -1% | -$543K |
|
963
Cinemark Holdings
CNK
$4.37B
| $38M | ﹤0.01% |
2,528,074
+20,970
| +0.8% | +$332K |
|
964
Five Star Bancorp
FSBC
$1.16B
| $38M | ﹤0.01% |
1,437,051
+419,779
| +41% | +$11.1M |
|
965
M&T Bank
MTB
$36.6B
| $37.9M | ﹤0.01% |
237,593
+48,937
| +26% | +$8.22M |
|
966
Brown-Forman Class B
BF.B
$12.9B
| $37.8M | ﹤0.01% |
539,195
-75,994
| -12% | -$5.09M |
|
967
CAE Inc. Common Shares
CAE
$8.47B
| $37.8M | ﹤0.01% |
1,538,442
+5,446
| +0.4% | +$135K |
|
968
Synaptics
SYNA
$4.2B
| $37.8M | ﹤0.01% |
320,223
+15,140
| +5% | +$2.22M |
|
|
TWTR
969
DELISTED
Twitter, Inc.
TWTR
| $37.8M | ﹤0.01% |
1,010,997
-137,424
| -12% | -$5.9M |
|
970
Canadian National Railway
CNI
$77.2B
| $37.8M | ﹤0.01% |
336,534
+149,356
| +80% | +$17.5M |
|
971
Tandem Diabetes Care
TNDM
$1.61B
| $37.6M | ﹤0.01% |
635,444
+7,747
| +1% | +$636K |
|
972
Kratos Defense & Security Solutions
KTOS
$11.8B
| $37.6M | ﹤0.01% |
2,705,664
+22,359
| +0.8% | +$348K |
|
|
DICE
973
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $37.5M | ﹤0.01% |
2,414,624
+270,940
| +13% | +$4.66M |
|
974
Blackstone
BX
$112B
| $37.2M | ﹤0.01% |
407,568
-3,272
| -0.8% | -$353K |
|
975
NCR Voyix
VYX
$1.17B
| $37.1M | ﹤0.01% |
1,946,447
+22,742
| +1% | +$485K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.